What's new

Human medicines European public assessment report (EPAR): Eksunbi, ustekinumab, Date of authorisation: 12/09/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Eksunbi, ustekinumab, Date of authorisation: 12/09/2024, Revision: 2, Status: Authorised

May 26, 2025 - 16:15
 0
Human medicines European public assessment report (EPAR): Eksunbi, ustekinumab, Date of authorisation: 12/09/2024, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Eksunbi, ustekinumab, Date of authorisation: 12/09/2024, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

STAT+: GSK drug’s new approval sets up competition with Dupixent

Next Article

Human medicines European public assessment report (EPAR): Otulfi, ustekinumab, D...

Related Posts

Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Levetiracetam Hospira, levetiracetam, Date of authorisation: 07/01/2014, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0

EMEA-003063-PIP03-22

EMEA-003063-PIP03-22

May 26, 2025  0